financetom
Business
financetom
/
Business
/
Private equity firm Advent to sell drugmaker Zentiva to GTCR
News World Market Environment Technology Personal Finance Politics Retail Business Economy Cryptocurrency Forex Stocks Market Commodities
Private equity firm Advent to sell drugmaker Zentiva to GTCR
Sep 11, 2025 6:12 AM

Sept 11 (Reuters) - Czech generic drugmaker Zentiva

said on Thursday that private equity group Advent

International had agreed to sell the company to rival GTCR for

an undisclosed value.

The Financial Times had first reported the deal on

Wednesday, saying it was worth 4.1 billion euros ($4.80

billion).

($1 = 0.8540 euros)

Comments
Welcome to financetom comments! Please keep conversations courteous and on-topic. To fosterproductive and respectful conversations, you may see comments from our Community Managers.
Sign up to post
Sort by
Show More Comments
Related Articles >
Copyright 2023-2026 - www.financetom.com All Rights Reserved